Cytek Biosciences, Inc. CTKB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $28.98M-70.6% | $98.75M-41.0% | $167.3M-43.6% | $296.6M-18.7% | ||
| $230.4M+10.7% | $208.17M+2.0% | $204.05M+31.0% | $155.72M+92.2% | ||
| $194.91M-0.3% | $195.51M-25.7% | $262.99M+45.4% | $180.85M+101% | ||
| $392M-1.1% | $396.45M+1.1% | $392.06M-13.6% | $454.02M+5.2% | ||
| $18.01M+0.3% | $17.96M-2.4% | $18.41M+34.5% | $13.68M+134% | ||
| $16.7M+0.2% | $16.66M+3.0% | $16.18M+59.5% | $10.14M0.0% | ||
| $16.82M-16.4% | $20.13M-12.8% | $23.08M+433% | $4.33M-8.6% | ||
| $461.54M-7.6% | $499.5M+1.0% | $494.46M-4.8% | $519.48M+12.1% | ||
| $27.14M+52.2% | $17.83M+10.7% | $16.11M-30.5% | $23.17M+123% | ||
| $28.5M+77.1% | $16.1M+6.4% | $15.13M+15.3% | $13.12M+34.1% | ||
| $77.8M+15.0% | $67.66M+20.3% | $56.23M+14.7% | $49.04M+47.8% | ||
| $525K-50.0% | $1.05M-36.3% | $1.65M-27.4% | $2.27M— | ||
| $119.8M+15.5% | $103.76M+2.3% | $101.39M+7.9% | $93.93M+62.2% | ||
| 1B+775,094% | 129K-1.5% | 131K-3.0% | 135K+7.1% | ||
| -$101.74M-189% | -$35.2M-20.6% | -$29.18M-71.3% | -$17.03M+13.1% | ||
| $341.74M-13.6% | $395.74M+0.7% | $393.06M-7.6% | $425.55M+5.0% | ||
| $461.54M-7.6% | $499.5M+1.0% | $494.46M-4.8% | $519.48M+12.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cytek Biosciences, Inc.'s total assets?
- Cytek Biosciences, Inc. (CTKB) holds $449.1M in total assets, down 6.9% year over year.
- How much debt does Cytek Biosciences, Inc. have?
- Cytek Biosciences, Inc. carries $16.8M in total debt against $327.6M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Cytek Biosciences, Inc. have?
- Cytek Biosciences, Inc. holds $31.8M in cash and equivalents.
- Can Cytek Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 4.69 — current assets exceed current liabilities.
- Where does Cytek Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
